R source code for real data applications using the proposed NURBS-based ROC estimator. by Mahmut Sami Erdoğan (22097195)

Subjects:

Estimated ROC curves with 95% bootstrap confidence bands for four nonparametric methods based on the FC dataset. by Mahmut Sami Erdoğan (22097195)

Subjects:

ASE values of eight different estimators for the last three different scenarios. by Mahmut Sami Erdoğan (22097195)

Subjects:

Comparison of ASE values with 95% bootstrap confidence intervals (CIs) and paired <i>t</i>-test <i>p</i>-values for NB6 vs kROC estimators under equal sample sizes (). by Mahmut Sami Erdoğan (22097195)

Subjects:

Estimated ROC curves with 95% bootstrap confidence bands for four nonparametric methods based on the HL dataset. by Mahmut Sami Erdoğan (22097195)

Subjects:

Comparison of ASE values with 95% bootstrap confidence intervals (CIs) and paired <i>t</i>-test <i>p</i>-values for NB6 vs BP6 estimators under equal sample sizes (). by Mahmut Sami Erdoğan (22097195)

Subjects:

Estimated ROC curves with 95% bootstrap confidence bands for four nonparametric methods applied to the U96113_at gene. by Mahmut Sami Erdoğan (22097195)

Subjects:

Estimated ROC curves with 95% bootstrap confidence bands for four nonparametric methods applied to the U46006_s_at gene. by Mahmut Sami Erdoğan (22097195)

Subjects:

ASE values of eight different estimators for the first three different scenarios. by Mahmut Sami Erdoğan (22097195)

Subjects:

Maps of median projected λ_<i>S</i> (a) and <i>R</i>₀ (b) across 1st-level sub-national administrative regions in selected South American countries. by Keith Fraser (1868587)

Changes in AL (A) and SE (B) according to the treatment time estimation curve in patients given 0.125% atropine. by Zi-Rong Chen (9227618)

“…<p><b>(A)</b> The crucial period and outcome measurement period in the current study. …”

Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2018 ^a indicates ≥1.50 SD (17.9) from the mean (32.9... by Luke R. Cavanah (19022435)

Large state-wide variation (11.1-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2015 ^a indicates ≥1.50 SD (20.2) from the mean (36.... by Luke R. Cavanah (19022435)

Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2017 ^a indicates ≥1.50 SD (18.0) from the mean (33.1... by Luke R. Cavanah (19022435)

Large state-wide variation (8.5-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2019 ^a indicates ≥1.50 SD (16.8) from the mean (31.0... by Luke R. Cavanah (19022435)

Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2020 ^a indicates ≥1.50 SD (16.0) from the mean (29.9... by Luke R. Cavanah (19022435)

Large state-wide variation (10.2-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2016 ^a indicates ≥1.50 SD (19.2) from the mean (34.... by Luke R. Cavanah (19022435)

Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)